Refine
Language
- English (12)
Is part of the Bibliography
- yes (12) (remove)
Keywords
- diabetic nephropathy (2)
- Chronic kidney disease (1)
- Clinical study (1)
- Contrast induced acute kidney injury (1)
- Coronary angiography (1)
- Endothelial nitric oxide synthase (1)
- Endothelin (1)
- Kidney (1)
- Kynurenine (1)
- Major adverse kidney event (1)
- Mice (1)
- NGAL (1)
- Nitric oxide (1)
- Preinterventional biomarker (1)
- Radiocontrast media-induced nephropathy (1)
- Urinary ET-1 (1)
- acute kidney injury (1)
- asymmetric dimethylarginine (ADMA) (1)
- biomarkers of renal failure (1)
- blood biomarker (1)
- cardiac surgery (1)
- cardiovascular-disease (1)
- clusterin (1)
- contrast-induced nephropathy (1)
- cyclic-GMP (1)
- diabetic control (1)
- disease (1)
- early diagnosis (1)
- endothelial dysfunction (1)
- failure (1)
- guanylate cyclase (1)
- heart-failure (1)
- heart-type fatty acid binding protein (1)
- independent activation (1)
- intervention (1)
- kidney injury molecule 1 (1)
- molecule-1 KIM-1 (1)
- nephrin (1)
- neutrophil gelatinase-associated lipocalin (1)
- nitric-oxide (1)
- osteopontin (1)
- oxidative stress (1)
- pulmonary hypertension (1)
- pulmonary-hypertension (1)
- signal-transduction system (1)
- telmisartan (1)
- therapeutic target (1)
- tissue inhibitior of metalloproteinases 1 (1)
- urinary biomarker (1)
Background/Aims: Contrast induced acute kidney injury (CI-AKI) remains a serious complication of contrast media enhanced procedures like coronary angiography. There is still a lack of established biomarkers that help to identify patients at high risk for short and long-term complications. The aim of the current study was to evaluate plasma kynurenine as a predictive biomarker for CI-AKI and long-term complications, measured by the combined endpoint "major adverse kidney events" (MAKE) up to 120 days after CM application.
Methods: In this prospective cohort study 245 patients undergoing coronary angiography were analyzed. Blood samples were obtained at baseline, 24h and 48h after contrast media (CM) application to diagnose CI-AKI. Patients were followed for 120 days for adverse clinical events including death, the need for dialysis, and a doubling of plasma creatinine. Occurrence of any of these events was summarized in the combined endpoint MAKE.
Results: Preinterventional plasma kynurenine was not associated with CI-AKI. Patients who later developed MAKE displayed significantly increased preinterventional plasma kynurenine levels (p<0.0001). ROC analysis revealed that preinterventional kynurenine is highly predictive for MAKE (AUC=0.838; p<0.0001). The optimal cutoff was found at >= 3.5 mu mol/L. Using this cutoff, the Kaplan-Meier estimator demonstrated that concentrations of plasma kynurenine >= 3.5 mu mol/L were significantly associated with a higher prevalence of MAKE until follow up (p<0.0001). This association remained significant in multivariate Cox regression models adjusted for relevant factors of long-term renal outcome.
Conclusion: Preinterventional plasma kynurenine might serve as a highly predictive biomarker for MAKE up to 120 days after coronary angiography.
Background/Aims: To investigate the renal phenotype under conditions of an activated renal ET-1 system in the status of nitric oxide deficiency, we compared kidney function and morphology in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxide synthase knockout (eNOS-/-) and ET+/+eNOS-/- mice. Methods: We assessed blood pressure, parameters of renal morphology, plasma cystatin C, urinary protein excretion, expression of genes associated with glomerular filtration barrier and tissue remodeling, and plasma metabolites using metabolomics. Results: eNOS-/- and ET+/+eNOS-/- mice developed hypertension. Osteopontin, albumin and protein excretion were increased in eNOS-/- and restored in ET+/+eNOS-/- animals. All genetically modified mice developed renal interstitial fibrosis and glomerulosclerosis. Genes involved in tissue remodeling (serpinel, TIMP1, Collal, CCL2) were up-regulated in eNOS-/-, but not in ET+/+eNOS-/- mice. Plasma levels of free carnitine and acylcarnitines, amino acids, diacyl phosphatidylcholines, lysophosphatidylcholines and hexoses were descreased in eNOS-/- and were in the normal range in ET+/+eNOS-/- mice. Conclusion: eNOS-/- mice developed renal dysfunction, which was partially rescued by ET-1 overexpression in eNOS-/- mice. The metabolomics results suggest that ET-1 overexpression on top of eNOS knockout is associated with a functional recovery of mitochondria (rescue effect in 13-oxidation of fatty acids) and an increase in antioxidative properties (normalization of monounsaturated fatty acids levels). (C) 2015 The Author(s) Published by S. Karger AG, Basel